State of the Art and Future Directions of Synthetic Biology-Armed Vaccine Development
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 13361
Special Issue Editors
Interests: synthetic biology; synthetic cells; origin of life; liposome; protein and vaccine production
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Synthetic biology provides novel approaches for rebuilding existing biological systems or redesigning new ones from scratch for various applications. Over time, the so-called “bottom-up” synthetic biology has expanded to many research subjects, including biology, chemistry, computational sciences, and engineering. The state-of-the-art concepts and strategies of synthetic biology can also activate and shape the future of vaccine development into the next generation. Thus, we would like to invite researchers worldwide to contribute to this Special Issue with recent advances in the vaccine/antibody production and mechanism study armed with rational designs from synthetic biology. We welcome high-quality mini-review and research articles with results from various host models aimed at either laboratory or industrial level. Articles on synthetic cell-based antigen display or drug delivery systems are also welcome.
Dr. Jian Xu
Dr. Jae Man Lee
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine development
- synthetic biology
- bottom-up approach
- antigen production
- synthetic cell
- drug delivery system
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.